Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 290 participants.
Also called NCT05516446
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 290 participants
- Registry
-
NCT05516446
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Tunisia
- Registry status
- Unknown status
Technical summary
Registry record NCT05516446. Randomized; single masking; primary purpose treatment. Start 2021-08-25 (actual); primary completion 2022-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent
- Acronym
- DEBATE
- Condition
- De Novo Stenosis
- Intervention (Device)
- DEB for de Novo Lesions
- Intervention (Device)
- DES for de Novo Lesions
- Lead sponsor
- General Administration of Military Health, Tunisia
- Collaborator
- B. Braun Medical International Trading Company Ltd.
Record details
- Record id
cardio:ct-nct05516446- Content hash
ca8ada337ee8859251210716cca07416558a95feb253df1696f65d4ef46aa59d